|
|
| Model Number |
SIG30CTAVM |
| Medical Device Problem Code |
Failure to Form Staple (2579)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); Laceration(s) (1946); Perforation of Vessels (2135); Great Vessel Perforation (2152); Tissue Breakdown (2681)
|
| Date of Event |
08/06/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
D10 concomitant product: sigpshell, sig power sigpshell control shell (lot #n4l1660y).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during a right upper lobectomy, the reload was loaded and fired with no issues; however, when the stapler was opened, the vein began to bleed rapidly.The proximal end of the vein, closest to the apex of the stapler, appeared cut but not stapled, with approximately 2mm.The patient lost approximately 1.3 liters of blood during surgery.A thoracotomy was required to access and suture the bleeding vein, and surgical time was extended by approximately half an hour.The patient was reported to be stable at the end of the procedure, and tumor removal was successful.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction: b1, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: d9, g3, h3, h6.H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.The evaluation found no potentially contributing factors, and the sample met all related specifications.It was reported that the proximal end of the vein, closest to the apex of the stapler, appeared cut but not stapled, approximately 2 millimeters (mm).The reported issue could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|